Advertisement
News
Subscribe to MDT Magazine News

Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities

February 28, 2011 4:34 pm | by EurekAlert | Comments

(American Society of Hematology) Results from a study published in Blood, the journal of the American Society of Hematology, reveal a close relationship between pulmonary arterial hypertension -- exceedingly high blood pressure in the arteries carrying blood from the heart to the lungs --...

TOPICS:

Feds awards $215 million pacts for flu vaccines

February 28, 2011 3:46 pm | by The Associated Press | Comments

Drug makers Novavax Inc. and VaxInnate Inc. have won contracts worth a combined $215 million to develop flu vaccines for the U.S. Department of Health and Human Services.The news sent shares of Novavax up 68 cents, or nearly 26 percent, to $3.19 in after-hours trading.The goal of the contracts...

Top scientists unite to develop global scientific strategy Towards An HIV Cure

February 28, 2011 10:38 am | by EurekAlert | Comments

(International AIDS Society) More than 30 scientists gathered for a one-day meeting prior to the 18th Conference on Retroviruses and Opportunistic Infections to launch an international working group on HIV reservoirs and strategies to control them. Under the auspices of the...

TOPICS:
Advertisement

Report: Inappropriate Antibiotic Use Still High Despite Educational Efforts

February 28, 2011 10:36 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Feb. 28, 2011 /PRNewswire-USNewswire/ – The Center for Healthcare Research & Transformation (CHRT) today released an issue brief showing continued high rates of inappropriate antibiotic use, despite a 15-year national outreach campaign by the Centers for...

TOPICS:

Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years

February 28, 2011 10:36 am | by Bio-Medicine.Org | Comments

LONDON, Feb. 28, 2011 /- The staffs of Chiltern International Limited (Chiltern), a global contract research organization (CRO), and Spectratox Limited, celebrate the 25 year mark of their successful collaboration in Drug Phototoxicity. Chiltern Early Phase and Spectratox have worked...

TOPICS:

Caprotec bioanalytics lands patent grant

February 28, 2011 8:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Caprotec bioanalytics GmbH, a Berlin-based biotechnology company with a subsidiary in Burlington, said Monday that the European Patent Office has granted the last of three core patents for its capture compound mass spectrometry technology.

TOPICS:

Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC

February 28, 2011 8:37 am | by Bio-Medicine.Org | Comments

BELGRADE, Mont., Feb. 28, 2011 /- Bacterin International Holdings, Inc. ("Bacterin") (OTC Bulletin Board: BIHI ), a developer of revolutionary bone graft material, today announced that its recently launched OsteoSponge®SC, a highly effective subchondral bone void filler, is being...

TOPICS:

Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System

February 28, 2011 8:35 am | by Bio-Medicine.Org | Comments

CHATTANOOGA, Tenn., Feb. 28, 2011 /- Glenveigh Medical, LLC and Monica Healthcare Limited today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Monica Healthcare's AN24 wireless fetal monitoring system. The...

TOPICS:
Advertisement

caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology

February 28, 2011 8:34 am | by Bio-Medicine.Org | Comments

BERLIN, and BURLINGTON, Mass., Feb. 28, 2011 /- caprotec bioanalytics GmbH announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry (CCMS) technology.   CCMS offers a...

TOPICS:

Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature

February 28, 2011 8:33 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Feb. 28, 2011 /- The Coalition for Ethical Imaging (CEI), a grassroots coalition with the goal of improving diagnostic imaging practices in Texas, is supporting House Bill 1809, sponsored by Representative Senfronia Thompson. The bill includes several initiatives that will...

TOPICS:

Stocks rise on more deal news, stable oil prices

February 28, 2011 5:45 am | by CHIP CUTTER - AP Business Writer - Associated Press | Comments

Stocks rose Monday after oil prices stabilized and corporations announced another round of deals.Ventas Inc., which owns senior housing communities, said it would buy Nationwide Health Properties Inc. in a $5.8 billion deal that will create the largest U.S. health care real-estate investment...

Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue

February 28, 2011 5:39 am | by EurekAlert | Comments

(Microbicide Trials Network) In the first head-to-head study of tenofovir gel and oral tenofovir -- two promising approaches for preventing HIV in women -- researchers found daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal...

TOPICS:

Cardiorobotics collects $6.5M in new funding

February 28, 2011 5:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Raynham-based Cardiorobotics Inc. has raised $6.5 million of a planned $12.5 million funding round, composed of equity and options-based securities, according to federal documents.

AACR to Host U.S. Surgeon General at Congressional Briefing on America's Continuing Tobacco Problem

February 28, 2011 5:35 am | by AACR | Comments

WASHINGTON, D.C. - U.S. Surgeon General Regina M. Benjamin, M.D., M.B.A., will discuss the dangers of tobacco use and her office's recently released report on smoking at an American Association for Cancer Research-sponsored congressional briefing on Tuesday, March 1, 2011.

TOPICS:

Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd

February 28, 2011 4:35 am | by Bio-Medicine.Org | Comments

VANCOUVER, British Columbia, Feb. 28, 2011 /- Allon Therapeutics Inc. (TSX: NPC), today announced that Gordon C. McCauley, President and CEO, will present at RetailInvestorConferences.com.DATE: March 3rd, 2011TIME: 3:00 PM ESTLINK: www.retailinvestorconferences.com This will be a live,...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading